Cresco Labs, a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced the Florida expansion of its premium flagship brand, Cresco. Now available for purchase at the company’s 19 Sunnyside stores throughout the state, Cresco launches with its multi-market leading Liquid Live Resin (“LLR”) vapes and Live Resin concentrates.
“Florida’s medical patients use cannabis regularly for their diverse health and wellness needs and gravitate towards premium branded products for their high quality, consistent experiences,” said Cris Rivera, Florida Regional President at Cresco Labs. “Cresco’s Liquid Live Resin vapes and Live Resin concentrates will not only offer top quality, repeatedly favorable experiences, but also will provide our patients with the confidence and assurance that they are consuming trusted, safe cannabis products with nothing added or taken away from a single strain. With the addition of Cresco to Sunnyside’s brand assortment, we’re excited to give our patients more choice in vape and concentrate forms across price points, potencies, flavor profiles, strains and more.”
Throughout September and the coming months, the following Cresco products will be available exclusively at Sunnyside:
- Liquid Live Resin Vape Cartridges: Cresco’s LLR for vaping is unique and fundamentally different from other vapes in the market today. Cresco Labs uses a patented Butane Hash Oil (BHO) post-extraction process that starts with a single strain harvested and extracted at peak freshness and results in the preservation of the strain’s original full-spectrum effects, flavor and terpenes. Nothing is added or taken away. It’s pure cannabis, and nothing else. Available now in 500mg for $55 and soon in 1g for $95.
- Live Resin Concentrates: Utilizing the same BHO extraction process as LLR from premium, fresh-frozen flower without artificial flavors or fillers. Cresco’s Live Resin Budder, Sugar and Sauce forms are for dabbing. They are strain-specific, robust in flavor and aroma, potent and capture the complexity of the plant. Consistency is the main difference among the four forms.
- Budder: A smooth and creamy texture like peanut butter. Available now in 1g for $65.
- Sugar: A shimmering, crystalline consistency like thick sugar or raw honey. Available now in 1g for $65.
- Sauce: A syrupy, liquid consistency with granular crystals that is high in terpenes. Available soon in 1g for $65.
- THCa Crushed Diamonds: Brand-new to Cresco’s portfolio, a potent concentrate that is similar in appearance to diamonds with solid crystalline structures. Available soon in 1g for $65.
Cresco’s LLR is the No. 1 bestselling vape cart in Illinois and Pennsylvania. Its Live Resin concentrates are No. 1 in Pennsylvania and No. 2 in Illinois, as of the most recent data from the second quarter of 2022 according to BDS Analytics, a cannabis data company.
At Sunnyside, patients have access to one of the widest selections of products from Cresco Labs’ One Plant, Supply, Good News, Remedi, Sunnyside Chews and now Cresco brands.
In Florida, Cresco Labs operates 19 Sunnyside stores in: Avon Park, Bonita Springs, Boynton Beach, Cape Coral, Clearwater, Fort Lauderdale, Jacksonville Beach, Lady Lake, North Miami, Ocala, Oakland Park, Orlando (Fern Park), Panama City Beach, Pensacola, Port St. Lucie, Sarasota, St. Petersburg, Tallahassee and Tampa.
For more information about Sunnyside or to place online orders, visit www.sunnyside.shop. To learn more about Cresco, visit www.crescocannabis.com.
About Cresco Labs Inc.
Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy’s Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs’ national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com.
Facebook: Cresco Labs
Instagram: Cresco Labs
Twitter: Cresco Labs
Forward-Looking Statements
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as, ‘may,’ ‘will,’ ‘should,’ ‘could,’ ‘would,’ ‘expects,’ ‘plans,’ ‘anticipates,’ ‘believes,’ ‘estimates,’ ‘projects,’ ‘predicts,’ ‘potential’ or ‘continue’ or the negative of those forms or other comparable terms. The Company’s forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to those risks discussed under “Risk Factors” in the Company’s Annual Information Form for the year ended December 31, 2020 filed on March 26, 2021, and other documents filed by the Company with Canadian securities regulatory authorities; and other factors, many of which are beyond the control of the Company. Readers are cautioned that the foregoing list of factors is not exhaustive. Because of these uncertainties, you should not place undue reliance on the Company’s forward-looking statements. No assurances are given as to the future trading price or trading volumes of Cresco Labs’ shares, nor as to the Company’s financial performance in future financial periods. The Company does not intend to update any of these factors or to publicly announce the result of any revisions to any of the Company’s forward-looking statements contained herein, whether as a result of new information, any future event or otherwise. Except as otherwise indicated, this press release speaks as of the date hereof. The distribution of this press release does not imply that there has been no change in the affairs of the Company after the date hereof or create any duty or commitment to update or supplement any information provided in this press release or otherwise.
###
